Abstract-Objective: Musculoskeletal modeling has been used to predict the effect of functional electrical stimulation (FES) on the mechanics of the musculoskeletal system. However, validation of the resulting muscle activations due to FES is challenging as conventional electromyography (EMG) recording of signals from the stimulated muscle is affected by stimulation artefacts. A validation approach using a combination of musculoskeletal modeling and EMG was proposed, whereby the effect on nonstimulated muscles is assessed using both techniques. The aim is to quantify the effect of FES on biceps femoris long head (BFLH) and validate this directly against EMG of gluteus maximus (GMAX). The hypotheses are that GMAX activation correlates with BFLH activation; and the muscle activation during FES gait can be predicted using musculoskeletal modeling. Methods: Kinematics, kinetics, and EMG of healthy subjects were measured under four walking conditions (normal walking followed by FES walking with three levels of BFLH stimulation). Measured kinematics and kinetics served as inputs to the musculoskeletal model. Results: Strong positive correlations were found between GMAX activation and BFLH activation in early stance peak (R = 0.78, p = 0.002) and impulse (R = 0.63, p = 0.021). The modeled peak and impulse of GMAX activation increased with EMG peak (p < 0.001) and impulse (p = 0.021). Conclusion: Musculoskeletal modeling can be used reliably to quantify the effect of FES in a healthy gait. Significance: The validation approach using EMG and musculoskeletal modeling developed and tested can potentially be applied to the use of FES for other muscles and activities.
I. INTRODUCTION
F UNCTIONAL electrical stimulation (FES) involves utilising patterned electrical stimulation to nervous tissue in order to activate muscles [1] . The beneficial effects of FES have been demonstrated for individuals with neurological pathologies [2] - [5] . Investigations have been made to artificially elicit and control lower limb muscle contraction via FES thereby utilising the musculature and metabolic power supply of individuals to generate locomotion [2] , [4] , [6] . In addition to the restoration of lower limb movement, FES-aided gait has also been shown to have potential benefits for individuals with orthopaedic pathologies, including mitigation of medial knee loading for patients with knee osteoarthritis (OA) [7] , [8] , and improvement in knee stability for patients with anterior cruciate ligament (ACL) injuries [9] , [10] .
In order to control graded force recruitment from selective muscles and produce well-coordinated movement via FES, the knowledge of muscle activations in magnitude and timing is important. Advances in computational musculoskeletal gait models provide promising, non-invasive determination of mechanical loading in a musculoskeletal system. Such models take as input measured kinematics (joint angles and segment positions) and kinetics (ground reaction force and segmental parameters) during gait to formulate the equations of motion; solving these yields muscle, joint and ligament forces. However, validating the results from the musculoskeletal models is a well-known challenge [11] - [13] . Validation can be achieved at the level of tendon forces, bone forces or joint contact forces using invasive devices, for example instrumented prostheses [14] , [15] or tendon transducers [16] . Alternatively, validation is possible at the level of muscle activations with surface electromyography (EMG) [17] , [18] . EMG signals are affected by the stimulation artefacts caused by the stimulation current when FES is used. This has been partially addressed in the literature with, for example, use of an EMG-amplifier with shut-down control [19] , advanced filtering procedures [19] - [21] , and optimising the positioning of the EMG electrodes in relation to the stimulation electrodes [20] , [22] . These approaches do not fully eliminate the stimulation artefacts.
Due to the difficulties in detecting EMG signals from the same electrically stimulated muscle, the approach proposed in this study is to measure EMG signals from a non-stimulated muscle that is sufficiently far removed from the stimulator. The muscle must also have the feature that it is likely to change its activation due to the disrupted mechanics produced by the stimulated muscle's increased activation. It is therefore necessary to identify such a pair of muscles, where the activation of one is likely to have an effect on the activation of the second muscle. Biceps femoris long head (BFLH) and gluteus maximus (GMAX) is a pair of the muscle candidates. BFLH acts as a knee flexor, and potentially compensates for weak hip extensors such as GMAX [23] . Clinically, stimulation of BFLH via FES has been used to generate hip extension for patients with paraplegia [6] , and improve knee stability for patients with ACL deficiency [24] . Therefore, BFLH is a clinically useful muscle in FES assisted gait. The aim of this study is to quantify the effect of FES on BFLH during gait utilising a musculoskeletal model and validate this directly against EMG of GMAX. The hypotheses of the study are that: GMAX activation correlates with BFLH activation; and the muscle activation pattern during FES gait with stimulation of BFLH can be predicted from the computational MSK model.
II. METHODS AND MATERIALS
The hypotheses were tested through computational modelling, three-dimensional gait analysis of healthy subjects under four walking conditions (normal walking followed by FES walking implemented in three output current amplitudes on BFLH), and the simultaneous measurement of EMG of GMAX. Thirteen healthy subjects (5 males and 8 females; mean height 1.65 ± 0.12 m; mass 64 ± 13 kg; age 26 ± 3 years) participated in the study. This study was approved by the institutional research ethics committee of Imperial College London and written informed consent was obtained from all participants.
A. Data Collection
Kinematic and kinetic data were collected in the motion laboratory, Department of Bioengineering, Imperial College London, UK. Eighteen retro-reflective markers were placed on the pelvis and the right lower limb (see Fig. 1 ) [10] . Their trajectories were captured at 200 Hz using a ten-camera motion capture system (VICON, Oxford Metrics Group, UK). Ground reaction forces of the right limb were recorded at 2000 Hz from a force plate (Kistler, Kistler Instrument AG, Switzerland). Initially, subjects performed six normal walking trials along an approximately six-metre level walkway at a self-selective comfortable walking speed, taking several steps prior to landing the right foot entirely on the force plate, and continuing for several steps. Following the normal walking trials, the skin of BFLH region was cleaned with a 70% isopropyl alcohol wipe and allowed to dry in seconds. Two rubber and gel electrodes (7 cm in diameter, PALS, Axelgaard manufacturing co., ltd, USA) were placed in the region: one in the centre between the ischial tuberosity to the lateral femoral epicondyle and the other one approximately 10 cm distally to the first (Fig. 1) . Electrical stimuli were delivered via the electrodes from a two-channel stimulator (O2CHS II, Odstock Medical Limited, UK), set at 40 Hz frequency with a pulse width of approximately 120 μs; this setting was tolerated by the majority of subjects in our previous study [10] . The output current amplitude was set to three stimulation levels of 40 mA, 60 mA and 80 mA. Six walking trials were measured for each stimulation level. To test that the BFLH stimulation was consistently applied between subjects, prior to FES gait, subjects were asked to stand with their legs straight and the stimulator was activated. The electrode positions and stimulation level were confirmed when a clear contraction of BFLH was observed through the resulting flexion of the right knee.
Surface EMG (Delsys, Trigno Wireless EMG System, USA) was sampled at 2000 Hz for BFLH and GMAX of the right limb. According to the SENIAM recommendations [25] sensors were placed at halfway along the line between the ischial tuberosity and the lateral femoral epicondyle for BFLH; and halfway along the line between the sacral vertebrae and the greater trochanter for GMAX. Prior to sensor placement, the skin area was shaved and cleaned with alcohol wipe to reduce skin impedance and to ensure electrode adhesion. During FES walking trials, the sensor at the region of BFLH was replaced with the FES electrodes. EMG was corrected for offset, high-pass filtered at 30 Hz using a zero phase-lag, four order Butterworth filter and rectified. The rectified signals were then low-pass filtered at 10 Hz [26] .
B. Lower Limb Musculoskeletal Model
An open source musculoskeletal modelling software Freebody was used (V2.1, [27] , [28] ). The segment-based lower limb model consists of the foot, shank, thigh, pelvis and patella segments. The model inputs are the kinematics data from the retro reflective markers and the kinetics data from the force plate. In terms of the inverse dynamics method, the model calculates the intersegmental forces and moments at the proximal end of each segment [29] .
Freebody's musculoskeletal dataset consists of 163 muscle elements representing 38 lower limb muscles. The muscle attachment sites, joint centres of rotation, and tibiofemoral contact points were manually digitized from the MR imaging of a male subject (1.83 m, 96.0 kg, 44.0 years) [27] . The model estimates the muscular and joint reaction forces experienced by the lower limb during the recorded movement. The optimisation was performed using the cost function in order to minimise the sum of the cubed muscle activations [30] as:
where f i is the muscle force of muscle element i (i = 1, . . . , 163) and f m ax i is the maximum muscle force of muscle element i, which is determined by multiplying published physiological cross-sectional areas of muscle element i by an assumed maximum muscle stress of 31.39 N/cm 2 [31] , constrained by the equations of motion of the whole lower limb as:
where i is the segment number or joint number (numbering from distal to proximal), S i the proximal inter-segmental forces, S i−1 the distal inter-segmental forces, M i the proximal intersegmental moments (notional joint moments), M i−1 the distal inter-segmental moments (notional joint moments), I i the inertia tensor,θ i the angular acceleration about COM,θ i the angular velocity about the COM, a i the linear acceleration of COM, m i the segment mass, E 3X 3 the identity matrix, c i the vector from the proximal joint to the segment COM and d i is the vector from the proximal to the distal joint.
C. Revised Optimisation Method
In order to simulate the effect of three FES current levels applied to BFLH, a modified optimisation method was used [10] . In this method the muscle force of BFLH is set as a constant value during the stance phase which is equal to the muscle activation, c, times the maximum force of BFLH. As the attachment sites of BFLH are on the shank and thigh segments, the equations of motion of the shank and thigh segments were modified by the inclusion of an additional term to give:
where c is a constant, f BFLH m ax the maximum force of BFLH, n BFLH the line of action of BFLH and r BFLH the moment arm of BFLH. The muscle forces of the remaining 162 muscles were re-optimised based on the modified equations of motion. From our previous study, a mean BFLH activation value of 0.208 reduces the peak anterior shear force below zero [10] which is the maximum desired clinical outcome for those with ACL deficiency. In this study, c was set to 0.10, 0.15 and 0.20; these are all greater than the BFLH activation predicted from normal optimisation and not greater than the maximum value required from the previous study. Measured kinematics and kinetics during normal walking and walking with FES currents of 40 mA, 60 mA and 80 mA were set as inputs for the normal optimisation as well as for revised optimisation with c values of 0.10, 0.15 and 0.20, respectively.
D. Data Analysis and statistics
Per subject, three random selected walking trials for each of the four conditions were processed. GMAX EMG activity was defined as the processed signals normalized by the peak value from 12 walking trials (3 walking trials × 4 conditions); this varied from 0 to 1. EMG activity and modelled activation were expressed as a percentage of the stance phase (0% is right heel strike and 100% is right heel off). Time-integrated measures (impulses) of EMG activity and modelled activation were determined using the trapezoidal method of numerical integration [32] .
Statistical analysis was performed using SPSS (Version 24.0, IBM Corp., USA). Significance was set at an alpha level of 0.05. Linear regression analyses were performed to evaluate the relationship between GMAX activation and BFLH activation. Difference between conditions at walking speed, early stance peak, timing and impulse of EMG activity and modelled activation of GMAX were assessed using either one-way repeated measures ANOVA (for normally distributed variables, as inspected from the Shapiro-Wilk test) or Friedman tests (for non-normally distributed variables). Where results were significant, pairwise comparisons were performed with a Bonferroni correction for multiple comparisons. The relationship between the modelled muscle activation and EMG activity was investigated using the Restricted Maximum Likelihood (REML) linear mixed model analysis with subjects considered as the random factor. Dependent variables were the predicted GMAX early stance peak and impulse. EMG activity early stance peak and impulse were the fixed effects.
III. RESULTS
Across 13 subjects, modelled GMAX activation was plotted against the modelled BFLH activation (see Fig. 2 ). Strong positive correlations were found in early stance peak (R = 0.78, p = 0.002) and impulse (R = 0.63, p = 0.021).
All subjects tolerated FES output currents of 40 mA and 60 mA. One subject did not tolerate the output current of 80 mA and therefore results for FES walking with 80 mA stimulation are for 12/13 subjects.
Measured and modelled variables during stance are reported in Table I . Walking speed did not change across conditions (p = 0.663). GMAX EMG activity peak occurred at 13% (±2%) of stance, the timing of which did not change across conditions (p = 0.470). Early stance peak and impulse of GMAX EMG activity increased significantly from normal walking to FES walking (p < 0.001). The musculoskeletal modelling predicted GMAX activation peak at 27% (±1%) of stance with a lag of 14% (±2%) stance from the EMG measurement; this did not change between conditions (p = 0.063). Modelled early stance peak and impulse of GMAX activation increased significantly from normal walking to FES walking (p < 0.001).
Measured EMG activity and modelled GMAX activation is plotted in Fig. 3 for a representative subject. During early stance, the peak EMG activity was lowest for normal walking, and was positively correlated to current amplitude in FES walking. Greater c values in the optimisation models contributed to greater GMAX activation. The increase of GMAX activation peak and impulse followed the increase of EMG peak and impulse (see Fig. 3 (c) and (d)). Linear mixed models (see Table II ) confirmed that the modelled peak and impulse of GMAX activations increased with EMG peak (p < 0.001) and impulse (p = 0.021).
IV. DISCUSSIONS
The purpose of the study was to quantify the effect of FES on BFLH using MSK modelling and validate this directly against EMG of GMAX. The first hypothesis that GMAX activation correlates with BFLH activation was confirmed through strong positive correlations between GMAX activation and BFLH activation in early stance peak (R = 0.78, p = 0.002) and impulse (R = 0.63, p = 0.021). The second hypothesis that these activations can be quantified through musculoskeletal modelling was also confirmed through validation using EMG. In the musculoskeletal model, muscle activations were calculated, constrained by the experimental measured kinematics and kinetics, and the modified BFLH activation to represent the stimulation at the output currents of 40 mA, 60 mA and 80 mA. The modelled early stance peak and impulse of GMAX activation significantly correlated with the early stance peak and impulse of EMG activity (p ࣘ 0.021). However, there was a consistent electromechanical delay of approximately 95 ms between measured EMG and modelled activation. This is comparable to other studies [33] , [34] . Where others have used musculoskeletal models to quantify the effect of FES, none have validated these models against simultaneously measured EMG signals. An alternative to the method proposed here would be to use instrumented implant validation for studies combined with FES; such as has been used to validate musculoskeletal modelling for the hip and knee [15] , [35] .
In this study BFLH was selected because of its clinical relevance: it has been used to generate hip extension for patients with paraplegia [6] and to improve knee stability for patients with ACL deficiencies [24] . There are other clinical conditions where muscle activation could be used therapeutically, for example, to correct foot drop following stroke through the stimulation of tibialis anterior [5] or to attenuate muscle atrophy associated with total knee arthroplasty through the stimulation of vastus medialis [36] . The validation approach developed and tested here could potentially be used in these applications.
This study has some limitations. First, the test cohort comprised only healthy, able-bodied subjects. In order to study the clinical effect of FES on patients with neuromuscular disorders, kinematics and kinetics from patient groups are required as the movement strategies may be different from those of healthy subjects [37] . Patient-specific musculoskeletal modelling for these subjects would also enhance the modelling fidelity as some parameters in the model may need to be adjusted in order to represent the morphological changes due to the disorders, such as changes in muscle size and attachments [38] .
In this study, muscle force during gait was quantified by minimising the sum of muscle activations cubed [27] . When compared with EMG measurement, this criterion has been shown to accurately predict muscle activation pattern during gait, cycling and other similar functional activities for healthy subjects [32] , [39] . However, for patients with neuromuscular disorders, other physiological cost functions may be more representative of their movement strategies [40] , [41] . Additionally, we recognize that EMG is not an absolute measure of muscle activation, and is appropriately used as a measure of change in activation [13] .
The experiments in this study consistently measured first normal walking and then FES walking at increasing intensities. This approach was chosen to eliminate unwanted kinematics effects due to fatigue and discomfort. However, this may have introduced some bias and, therefore, for a systematic investigation of FES intervention during gait, the walking conditions could be randomized.
V. CONCLUSION
The study is the first to have validated the use of musculoskeletal modelling to quantify the effect of FES during gait in healthy subjects. The specific use, in this study, of FES for BFLH was shown to predictably increase GMAX activation. We propose using this approach to quantify the effect of FES on other muscles and activities.
